[Relationship between interleukin-6 gene polymorphism and coronary heart disease and its effect on plasma lipid levels].

Autor:	Wei YS; Department of Clinical Laboratory Center, The Affiliated Hospital to Youjiang Nationality Medical College, Youjiang 533000, Guangxi, China. weiyesheng@yahoo.com.cn, Lan Y, Liu YG, Tang RG, Lan JS
Jazyk:	čínština
Zdroj:	Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue [Zhongguo Wei Zhong Bing Ji Jiu Yi Xue] 2006 Apr; Vol. 18 (4), pp. 233-6.
Abstrakt:	Objective: To study the relationship between interleukin-6 (IL-6) gene promoter-572 C/G and -634 C/G polymorphism and coronary heart disease (CHD) and the influence of IL-6 gene polymorphism on plasma lipid and lipoprotein levels. Methods: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used for the detection of IL-6 genotype in 165 patients with CHD and 170 healthy persons. The plasma lipid and lipoprotein levels were measured by routine method. Results: Plasma total cholesterol (TC), triglyceride (TG) and low density lipoprotein cholesterol (LDL-C) of the patients with CHD were significantly higher than those of the controls (all P<0.05). The distributions of IL-6 gene -634 C/G polymorphism were not different between CHD group and control group (P>0.05), but the IL-6 gene-572 C/G polymorphism was significantly different between them (P<0.05). The relative risk of CHD of C allele was 1.652 times to the G allele [odds ratio (OR)=1.652, 95% confidence interval (CI): 1.137-2.401]. The level of plasma lipid in G allele carriers was significantly higher than non-carriers (P<0.05). Conclusion: IL-6 gene -572 C/G polymorphism is associated with CHD, and G allele is an important genetic marker. IL-6 gene polymorphism may affect CHD through elevation of plasma lipid and lipoprotein levels.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu